TABLE OF CONTENTS
1 INTRODUCTION 47
1.1 OBJECTIVES OF THE STUDY 47
1.2 MARKET DEFINITION 47
1.3 OVERVIEW OF THE NORTH AMERICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET 47
1.4 LIMITATIONS 49
1.5 MARKETS COVERED 49
2 MARKET SEGMENTATION 52
2.1 MARKETS COVERED 52
2.2 GEOGRAPHICAL SCOPE 53
2.3 YEARS CONSIDERED FOR THE STUDY 54
2.4 CURRENCY AND PRICING 54
2.5 DBMR TRIPOD DATA VALIDATION MODEL 55
2.6 MULTIVARIATE MODELLING 58
2.7 PRODUCT TYPE LIFELINE CURVE 58
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 59
2.9 DBMR MARKET POSITION GRID 60
2.10 MARKET APPLICATION COVERAGE GRID 61
2.11 VENDOR SHARE ANALYSIS 62
2.12 SECONDARY SOURCES 63
2.13 ASSUMPTIONS 63
3 EXECUTIVE SUMMARY 64
4 PREMIUM INSIGHTS 67
4.1 PESTEL ANALYSIS 68
4.2 PORTER'S FIVE FORCES MODEL 69
4.3 NUMBER OF HOSPITALS ANALYSIS: NORTH AMERICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET 70
4.4 PATENT ANALYSIS OF NORTH AMERICA ELECTROMAGNETIC TRACKING SYSTEMS 71
5 VALUE CHAIN ANALYSIS: NORTH AMERICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET 73
6 INDUSTRY INSIGHTS FOR NORTH AMERICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET 74
6.1 KEY PRICING STRATEGIES 74
6.1.1 PRODUCT INNOVATION 74
6.1.2 CONSUMER AWARENESS 74
6.1.3 A VAST NETWORK OF DISTRIBUTION 75
6.1.4 PARTNERSHIP BY MAJOR PLAYERS 75
6.1.5 IDENTIFICATION OF CUSTOMERS NEED FOR INNOVATIVE PRODUCTS 75
6.1.6 INCREASING SPECIFIC TACTICS FOR EVERY STEP 76
6.1.7 OTHERS 76
6.2 INTERVIEWS WITH MEDICAL DEVICES COMPANIES 76
6.3 INTERVIEWS WITH PHYSICIANS 77
6.4 INTERVIEWS WITH RESEARCH SCHOLAR 77
7 NORTH AMERICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET: REGULATIONS 79
8 MARKET OVERVIEW 83
8.1 DRIVERS 85
8.1.1 RISE IN DEMAND FOR VIRTUAL AND AUGMENTED REALITY TECHNOLOGY 85
8.1.2 GROWING USE OF ELECTROMAGNETIC TRACKING IN AEROSPACE AND DEFENSE 85
8.1.3 RISE IN COLLABORATION AND AGREEMENT OF ELECTROMAGNETIC TRACKING SYSTEMS MARKET PLAYERS WITH HOSPITALS AND OTHER MEDICAL SETTINGS 86
8.1.4 INCREASING DEMAND FOR ELECTROMAGNETIC SURGICAL NAVIGATION 87
8.2 RESTRAINTS 87
8.2.1 STRICT REGULATORY FRAMEWORKS 87
8.2.2 RISK ASSOCIATED WITH HIGH-DOSE RADIATION EXPOSURE 88
8.2.3 HIGH COMPETITION AMONG KEY PLAYERS 88
8.3 OPPORTUNITIES 89
8.3.1 INCREASING APPLICATION OF ELECTROMAGNETIC TRACKING SYSTEMS IN HEALTHCARE 89
8.3.2 GROWING INVESTMENT BY THE GOVERNMENT AND PRIVATE SECTOR 89
8.3.3 ADVANCEMENT IN THE MANUFACTURING INDUSTRY 90
8.4 CHALLENGES 91
8.4.1 HIGH COST OF SYSTEMS 91
8.4.2 ERRORS ASSOCIATED WITH THE INTERFERENCE DURING THE USE OF AN ELECTROMAGNETIC TRACKING SYSTEM 91
9 NORTH AMERICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET, BY PRODUCT TYPE 92
9.1 OVERVIEW 93
9.2 ORTHOPEDIC TRACKING SYSTEM 96
9.2.1 IMAGELESS ORTHOPEDIC SYSTEMS 97
9.2.2 RADIOGRAPHY ORTHOPEDIC SYSTEMS 97
9.2.3 CT-BASED ORTHOPEDIC SYSTEMS 97
9.2.4 FLUOROSCOPY-BASED NAVIGATION SYSTEMS 97
9.3 ENT TRACKING SYSTEM 97
9.3.1 OPTICAL SYSTEM 99
9.3.2 ELECTROMAGNETIC SYSTEM 99
9.3.3 HYBRID SYSTEM 99
9.4 CARDIAC TRACKING SYSTEMS 99
9.5 ELECTROPHYSIOLOGY TRACKING SYSTEMS 100
9.6 NEURONAVIGATION TRACKING SYSTEMS 101
9.6.1 OPTICAL SYSTEM 102
9.6.2 ELECTROMAGNETIC SYSTEM 102
9.7 DENTAL TRACKING SYSTEMS 102
9.8 OTHER SYSTEMS 103
10 NORTH AMERICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET, BY TECHNOLOGY 105
10.1 OVERVIEW 106
10.2 OPTICAL NAVIGATION SYSTEMS 109
10.3 ELECTROMAGNETIC (EM) NAVIGATION SYSTEMS 109
10.4 HYBRID NAVIGATION SYSTEMS 110
10.5 FLUOROSCOPY BASED NAVIGATION SYSTEM 111
10.6 OTHERS 112
11 NORTH AMERICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET, BY CONNECTIVITY 113
11.1 OVERVIEW 114
11.2 WIRED SYSTEMS 117
11.3 WIRELESS SYSTEMS 118
12 NORTH AMERICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET, BY MANEUVERABILITY 119
12.1 OVERVIEW 120
12.2 6-DOF 123
12.3 5-DOF 123
12.4 OTHERS 124
13 NORTH AMERICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET, BY END USER 125
13.1 OVERVIEW 126
13.2 HEALTHCARE FACILITIES 129
13.2.1 HOSPITALS 130
13.2.2 AMBULATORY SERVICE CENTERS 130
13.2.3 RESEARCH/ ACADEMIC INSTITUTIONS 130
13.3 MILITARY AND DEFENCE 130
13.4 INDUSTRIAL AUTOMATION 131
13.5 OTHERS 132
13.5.1 GAMING 133
13.5.2 MEDIA/PRODUCTION 133
13.5.3 SIMULATION AND TRAINING 133
13.5.4 OTHERS 134
14 NORTH AMERICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET, BY APPLICATION 135
14.1 OVERVIEW 136
14.2 ORTHOPEDIC TRACKING SYSTEM 139
14.2.1 DIAGNOSTIC 140
14.2.2 INTERVENTIONAL 140
14.3 ENT TRACKING SYSTEM 140
14.3.1 DIAGNOSTIC 141
14.3.2 INTERVENTIONAL 141
14.4 CARDIAC TRACKING SYSTEMS 141
14.4.1 DIAGNOSTIC 142
14.4.2 INTERVENTIONAL 143
14.5 ELECTROPHYSIOLOGY TRACKING SYSTEMS 143
14.5.1 DIAGNOSTIC 144
14.5.2 INTERVENTIONAL 144
14.6 NEURONAVIGATION TRACKING SYSTEMS 144
14.6.1 DIAGNOSTIC 145
14.6.2 INTERVENTIONAL 145
14.7 DENTAL TRACKING SYSTEMS 145
14.7.1 DIAGNOSTIC 146
14.7.2 INTERVENTIONAL 146
14.8 OTHER SYSTEMS 147
15 NORTH AMERICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET, BY DISTRIBUTION CHANNEL 148
15.1 OVERVIEW 149
15.2 DIRECT TENDER 152
15.3 RETAIL SALES 152
15.4 ONLINE SALES 153
16 NORTH AMERICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET, BY REGION 154
16.1 NORTH AMERICA 155
16.1.1 U.S. 166
16.1.2 CANADA 172
16.1.3 MEXICO 178
17 NORTH AMERICA ELECTROMAGNETIC TRACKING SYSTEMS MARKET, COMPANY LANDSCAPE 184
17.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 184
18 SWOT ANALYSIS 185
19 COMPANY PROFILE 186
19.1 TT ELECTRONICS 186
19.1.1 COMPANY SNAPSHOT 186
19.1.2 REVENUE ANALYSIS 186
19.1.3 COMPANY SHARE ANALYSIS 187
19.1.4 PRODUCT PORTFOLIO 187
19.1.5 RECENT DEVELOPMENT 187
19.2 NORTHERN DIGITAL INC 188
19.2.1 COMPANY SNAPSHOT 188
19.2.2 COMPANY SHARE ANALYSIS 188
19.2.3 PRODUCT PORTFOLIO 189
19.2.4 RECENT DEVELOPMENT 189
19.3 AMFITECH APS 190
19.3.1 COMPANY SNAPSHOT 190
19.3.2 COMPANY SHARE ANALYSIS 190
19.3.3 PRODUCT PORTFOLIO 191
19.3.4 RECENT DEVELOPMENT 191
19.4 RADWAVE TECHNOLOGIES INC. 192
19.4.1 COMPANY SNAPSHOT 192
19.4.2 COMPANY SHARE ANALYSIS 192
19.4.3 PRODUCT PORTFOLIO 193
19.4.4 RECENT DEVELOPMENT 193
19.5 OMMO TECHNOLOGIES 194
19.5.1 COMPANY SNAPSHOT 194
19.5.2 COMPANY SHARE ANALYSIS 194
19.5.3 PRODUCT PORTFOLIO 195
19.5.4 RECENT DEVELOPMENTS 195
19.6 POLHEMUS. 196
19.6.1 COMPANY SNAPSHOT 196
19.6.2 PRODUCT PORTFOLIO 196
19.6.3 RECENT DEVELOPMENTS 196
19.7 AUGMEDICS 197
19.7.1 COMPANY SNAPSHOT 197
19.7.2 PRODUCT PORTFOLIO 197
19.7.3 RECENT DEVELOPMENTS 197
19.8 B.BRAUN MELSUNGEN AG 198
19.8.1 COMPANY SNAPSHOT 198
19.8.2 REVENUE ANALYSIS 198
19.8.3 PRODUCT PORTFOLIO 199
19.8.4 RECENT DEVELOPMENT 199
19.9 BRAINLAB AG 200
19.9.1 COMPANY SNAPSHOT 200
19.9.2 PRODUCT PORTFOLIO 200
19.9.3 RECENT DEVELOPMENTS 200
19.10 CIRCINUS MEDICAL TECHNOLOGY. 201
19.10.1 COMPANY SNAPSHOT 201
19.10.2 PRODUCT PORTFOLIO 201
19.10.3 RECENT DEVELOPMENTS 201
19.11 ERGOSURG GMBH 202
19.11.1 COMPANY SNAPSHOT 202
19.11.2 PRODUCT PORTFOLIO 202
19.11.3 RECENT DEVELOPMENTS 202
19.12 FIAGON GMBH 203
19.12.1 COMPANY SNAPSHOT 203
19.12.2 PRODUCT PORTFOLIO 203
19.12.3 RECENT DEVELOPMENTS 203
19.13 HEAL FORCE 204
19.13.1 COMPANY SNAPSHOT 204
19.13.2 PRODUCT PORTFOLIO 204
19.13.3 RECENT DEVELOPMENTS 204
19.14 KARL STORZ SE & CO. KG. 205
19.14.1 COMPANY SNAPSHOT 205
19.14.2 PRODUCT PORTFOLIO 205
19.14.3 RECENT DEVELOPMENTS 205
19.15 KONINKLIJKE PHILIPS N.V. 206
19.15.1 COMPANY SNAPSHOT 206
19.15.2 REVENUE ANALYSIS 206
19.15.3 PRODUCT PORTFOLIO 207
19.15.4 RECENT DEVELOPMENT 207
19.16 MEDACTA INTERNATIONAL 208
19.16.1 COMPANY SNAPSHOT 208
19.16.2 REVENUE ANALYSIS 208
19.16.3 PRODUCT PORTFOLIO 209
19.16.4 RECENT DEVELOPMENT 209
19.17 MEDICAL DEVICE BUSINESS SERVICES, INC. 210
19.17.1 COMPANY SNAPSHOT 210
19.17.2 PRODUCT PORTFOLIO 210
19.17.3 RECENT DEVELOPMENTS 210
19.18 MEDTRONIC 211
19.18.1 COMPANY SNAPSHOT 211
19.18.2 REVENUE ANALYSIS 211
19.18.3 PRODUCT PORTFOLIO 212
19.18.4 RECENT DEVELOPMENT 212
19.19 ORTHALIGN 213
19.19.1 COMPANY SNAPSHOT 213
19.19.2 PRODUCT PORTFOLIO 213
19.19.3 RECENT DEVELOPMENT 213
19.20 SIEMENS AG 214
19.20.1 COMPANY SNAPSHOT 214
19.20.2 REVENUE ANALYSIS 214
19.20.3 PRODUCT PORTFOLIO 215
19.20.4 RECENT DEVELOPMENT 215
19.21 STRYKER 216
19.21.1 COMPANY SNAPSHOT 216
19.21.2 REVENUE ANALYSIS 216
19.21.3 PRODUCT PORTFOLIO 217
19.21.4 RECENT DEVELOPMENT 217
19.22 TOSHBRO MEDICALS PVT. LTD. 218
19.22.1 COMPANY SNAPSHOT 218
19.22.2 PRODUCT PORTFOLIO 218
19.22.3 RECENT DEVELOPMENTS 218
19.23 VERAN MEDICAL TECHNOLOGIES. 219
19.23.1 COMPANY SNAPSHOT 219
19.23.2 PRODUCT PORTFOLIO 219
19.23.3 RECENT DEVELOPMENT 219
19.24 ZIMMER BIOMET 220
19.24.1 COMPANY SNAPSHOT 220
19.24.2 REVENUE ANALYSIS 220
19.24.3 PRODUCT PORTFOLIO 221
19.24.4 RECENT DEVELOPMENT 221
20 QUESTIONNAIRE 222
21 RELATED REPORTS 226

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.